Fujian Aonong Biological Technology Group Incorporation Future Growth
Future criteria checks 5/6
Fujian Aonong Biological Technology Group Incorporation is forecast to grow earnings and revenue by 125.7% and 34.4% per annum respectively while EPS is expected to grow by 125.7% per annum.
Key information
125.7%
Earnings growth rate
125.7%
EPS growth rate
| Food earnings growth | 32.2% |
| Revenue growth rate | 34.4% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Jul 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 34,523 | 1,362 | 2,005 | 3,141 | 1 |
| 12/31/2024 | 31,990 | 1,469 | 1,673 | 2,588 | 1 |
| 3/31/2024 | 17,048 | -3,763 | 275 | 703 | N/A |
| 12/31/2023 | 19,458 | -3,651 | 472 | 984 | N/A |
| 9/30/2023 | 21,387 | -1,756 | 563 | 1,307 | N/A |
| 6/30/2023 | 22,862 | -1,171 | 123 | 1,211 | N/A |
| 3/31/2023 | 22,276 | -866 | -534 | 783 | N/A |
| 12/31/2022 | 21,613 | -1,038 | -835 | 664 | N/A |
| 9/30/2022 | 20,119 | -1,590 | -1,408 | 201 | N/A |
| 6/30/2022 | 18,636 | -2,034 | -1,394 | 87 | N/A |
| 3/31/2022 | 18,299 | -2,034 | -1,344 | 609 | N/A |
| 12/31/2021 | 18,038 | -1,520 | -2,184 | 524 | N/A |
| 9/30/2021 | 17,504 | -432 | -2,500 | 912 | N/A |
| 6/30/2021 | 15,649 | 72 | -3,375 | 791 | N/A |
| 3/31/2021 | 13,663 | 584 | -3,719 | 413 | N/A |
| 12/31/2020 | 11,517 | 573 | -2,887 | 406 | N/A |
| 9/30/2020 | 8,860 | 491 | -2,349 | 50 | N/A |
| 6/30/2020 | 7,165 | 346 | -1,414 | 104 | N/A |
| 3/31/2020 | 6,197 | 163 | -532 | 339 | N/A |
| 12/31/2019 | 5,788 | 29 | -264 | 394 | N/A |
| 9/30/2019 | 5,794 | 39 | -267 | 256 | N/A |
| 6/30/2019 | 5,736 | 35 | -237 | 248 | N/A |
| 3/31/2019 | 5,746 | 33 | -151 | 297 | N/A |
| 12/31/2018 | 5,762 | 30 | -542 | 27 | N/A |
| 9/30/2018 | 5,675 | 49 | -714 | -95 | N/A |
| 6/30/2018 | 5,376 | 61 | -766 | -136 | N/A |
| 3/31/2018 | 5,137 | 99 | -686 | -66 | N/A |
| 12/31/2017 | 4,903 | 108 | N/A | 42 | N/A |
| 9/30/2017 | 4,960 | 119 | N/A | 158 | N/A |
| 12/31/2016 | 4,978 | 91 | N/A | 129 | N/A |
| 12/31/2015 | 4,013 | 34 | N/A | 129 | N/A |
| 12/31/2014 | 4,184 | 43 | N/A | -34 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 603363 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: 603363 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 603363 is expected to become profitable in the next 3 years.
Revenue vs Market: 603363's revenue (34.4% per year) is forecast to grow faster than the CN market (14% per year).
High Growth Revenue: 603363's revenue (34.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 603363's Return on Equity is forecast to be high in 3 years time